Pulmonary Hypertension Trial, Recruiting NCT07366879 Sponsor: Golden Jubilee National Hospital Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07366879
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with a specific type of pulmonary hypertension (classified as Group I or non-operable Group IV) confirmed by a heart procedure called a right heart catheterisation, which showed specific pressure and resistance readings in your lungs (confirm with trial site for exact values)
  • You are able and willing to sign a consent form agreeing to take part

Who may not be able to join:

  • Your pulmonary hypertension is caused by a left heart problem (Group II), a lung disease related to low oxygen levels (Group III), a blood clot condition that can be treated with surgery (operable Group IV), or has unclear or multiple causes (Group V)
  • You are already taking part in, or planning to take part in, another clinical trial involving a research medication during the same period
  • Either you or your doctor has concerns about whether it would be safe for you to do an exercise programme at home
  • You have experienced fainting episodes that are thought to be related to your pulmonary hypertension around the time the exercise part of the trial would begin
  • You have a serious medical condition that would stop you from taking part in the study activities
  • Your doctors expect your life expectancy to be less than 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0044 141-951-5440

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Golden Jubilee National Hospital
Registry
ClinicalTrials.gov
Start date
2 April 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Six-minute walk distance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov